CPI-613 in Treating Patients With Myelodysplastic Syndromes Who Failed Previous Therapy

Stopped Drug sponsor suspended study prematurely then study was terminated. Expected enrollment was not met.

Conditions

• Previously Treated Myelodysplastic Syndromes

Interventions

• DRUG: 6,8-bis(benzylthio)octanoic acid

Sponsor

Wake Forest University Health Sciences

Collaborators

• [object Object]